Urinary MicroRNAs of Prostate Cancer: Virus-Encoded hsv1-miRH18 and hsv2-miR-H9-5p Could Be Valuable Diagnostic Markers
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Purpose: MicroRNAs (miRNAs) in biological fluids are potential biomarkers for the diagnosis and assessment of urological diseases such as benign prostatic hyperplasia (BPH) and prostate cancer (PCa). The aim of the study was to identify and validate urinary cell-free miRNAs that can segregate patients with PCa from those with BPH. Methods: In total, 1,052 urine, 150 serum, and 150 prostate tissue samples from patients with PCa or BPH were used in the study. A urine-based miRNA microarray analysis suggested the presence of differentially expressed urinary miRNAs in patients with PCa, and these were further validated in three independent PCa cohorts, using a quantitative reverse transcriptionpolymerase chain reaction analysis. Results: The expression levels of hsa-miR-615-3p, hsv1-miR-H18, hsv2-miR-H9-5p, and hsa-miR-4316 were significantly higher in urine samples of patients with PCa than in those of BPH controls. In particular, herpes simplex virus (hsv)-derived hsv1-miR-H18 and hsv2-miR-H9-5p showed better diagnostic performance than did the serum prostate-specific antigen (PSA) test for patients in the PSA gray zone. Furthermore, a combination of urinary hsv2-miR-H9-5p with serum PSA showed high sensitivity and specificity, providing a potential clinical benefit by reducing unnecessary biopsies. Conclusions: Our findings showed that hsv-encoded hsv1-miR-H18 and hsv2-miR-H9-5p are significantly associated with PCa and can facilitate early diagnosis of PCa for patients within the serum PSA gray zone.
Abstract
Purpose: MicroRNAs (miRNAs) in biological fluids are potential biomarkers for the diagnosis and assessment of urological diseases such as benign prostatic hyperplasia (BPH) and prostate cancer (PCa). The aim of the study was to identify and validate urinary cell-free miRNAs that can segregate patients with PCa from those with BPH. Methods: In total, 1,052 urine, 150 serum, and 150 prostate tissue samples from patients with PCa or BPH were used in the study. A urine-based miRNA microarray analysis suggested the presence of differentially expressed urinary miRNAs in patients with PCa, and these were further validated in three independent PCa cohorts, using a quantitative reverse transcriptionpolymerase chain reaction analysis. Results: The expression levels of hsa-miR-615-3p, hsv1-miR-H18, hsv2-miR-H9-5p, and hsa-miR-4316 were significantly higher in urine samples of patients with PCa than in those of BPH controls. In particular, herpes simplex virus (hsv)-derived hsv1-miR-H18 and hsv2-miR-H9-5p showed better diagnostic performance than did the serum prostate-specific antigen (PSA) test for patients in the PSA gray zone. Furthermore, a combination of urinary hsv2-miR-H9-5p with serum PSA showed high sensitivity and specificity, providing a potential clinical benefit by reducing unnecessary biopsies. Conclusions: Our findings showed that hsv-encoded hsv1-miR-H18 and hsv2-miR-H9-5p are significantly associated with PCa and can facilitate early diagnosis of PCa for patients within the serum PSA gray zone.
참고문헌 (21)
- Ambros V, "The functions of animal microRNAs", Nature, 431, pp.350~355 (2004)
- Bartel DP, "MicroRNAs: genomics, biogenesis, mechanism, and function", Cell, 116, pp.281~297 (2004)
- Calin GA, "Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers", Proc Natl Acad Sci U S A, 101, pp.2999~3004 (2004)
- Lu J, "MicroRNA expression profiles classify human cancers", Nature, 435, pp.834~838 (2005)
- Chen CZ, "MicroRNAs as oncogenes and tumor suppressors", N Engl J Med, 353, pp.1768~1771 (2005)
- 김성민, "Cell-Free microRNA-214 From Urine as a Biomarker for Non–Muscle-Invasive Bladder Cancer", Investigative and Clinical Urology, 54(11), pp.791~796 (2013), 대한비뇨기과학회
- Westermann AM, "Serum microRNAs as biomarkers in patients undergoing prostate biopsy: results from a prospective multi-center study", Anticancer Res, 34, pp.665~669 (2014)
- Yun SJ, "Cellfree microRNAs in urine as diagnostic and prognostic biomarkers of bladder cancer", Int J Oncol, 41, pp.1871~1878 (2012)
- Shen J, "Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer", Prostate, 72, pp.1469~1477 (2012)
- Bryant RJ, "Changes in circulating microRNA levels associated with prostate cancer", Br J Cancer, 106, pp.768~774 (2012)
- Delgado PO, "Characterization of cell-free circulating DNA in plasma in patients with prostate cancer", Tumour Biol, 34, pp.983~986 (2013)
- Jemal A, "Cancer statistics", CA Cancer J Clin, 60, pp.277~300 (2010)
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality and Survival in 2005", Journal of Korean Medical Science, 24(6), pp.995~1003 (2009), 대한의학회
- Andersen CL, "Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets", Cancer Res, 64, pp.5245~5250 (2004)
- Zhao Y, "Critical role of the virus-encoded microRNA-155 ortholog in the induction of Marek’s disease lymphomas", PLoS Pathog, 7, pp.e1001305~ (2011)
- Pfeffer S, "Identification of virus-encoded microRNAs", Science, 304, pp.734~736 (2004)
- Skalsky RL, "Viruses, microRNAs, and host interactions", Annu Rev Microbiol, 64, pp.123~141 (2010)
- Grundhoff A, "Virus-encoded microRNAs", Virology, 411, pp.325~343 (2011)
- Kincaid RP, "RNA virus microRNA that mimics a B-cell oncomiR", Proc Natl Acad Sci U S A, 109, pp.3077~3082 (2012)
- De Marzo AM, "Inflammation in prostate carcinogenesis", Nat Rev Cancer, 7, pp.256~269 (2007)
- Srivastava A, "MicroRNA profiling in prostate cancer--the diagnostic potential of urinary miR-205 and miR-214", PLoS One, 8, pp.e76994~ (2013)